News

Researchers at Cold Spring Harbor Laboratory have found that blocking the FGFR2 and EGFR genes can stop early-stage ...
Mohs surgery vs conventional excision was associated with decreased rates of reconstruction with positive margins for hand and foot melanoma.
A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of stage 3 melanoma patients with positive tests experience a return of cancer.
A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology. Abstract 853: ...
"Sun exposure causes damage to the cells in your skin and causes abnormal growth of melanocytes, which is a type of skin cell ...
Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.
HONG KONG SAR – Media OutReach Newswire – 22 April 2025 – CK Life Sciences Int’l., (Holdings) Inc. (“the Company”) announced ...
Companion Diagnostics MarketThe global market for companion diagnostics is set for exponential growth, projected to expand from USD 5,700.5 million in 2024 to USD 11,682.8 million by 2035, registering ...
Patients treated with trastuzumab deruxtecan + pertuzumab had a statistically significant and clinically meaningful improvement in PFS compared with standard of care. Topline results were ...
A new technique to mark peripheral pulmonary lesions (PPLs) before surgical resection was studied by Ganesh Krishna, M.D., a ...